← Browse by Condition
Medical Condition

obesity overweight

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3, EARLY_Phase 1, Phase 2
NCT07448090
Recruiting

Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity

Enrollment
10,000 pts
Location
China
Sponsor
Hubei Hospital of Traditional ...
View Trial →
NCT07227051
Recruiting

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health ...
View Trial →
NCT07279194 Phase 3
Recruiting

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Enrollment
825 pts
Location
China
Sponsor
Hangzhou Zhongmei Huadong Phar...
View Trial →
NCT07300332
Recruiting

Exercise Training and Vitamin D Metabolism

Enrollment
30 pts
Location
Greece
Sponsor
University of Thessaly
View Trial →
NCT07261475 EARLY_Phase 1
Recruiting

Crocus Sativus Tepals Water Extract in Obesity and Prediabetes

Enrollment
20 pts
Location
Slovenia
Sponsor
University of Primorska
View Trial →
NCT07229027
Recruiting

Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Enrollment
500 pts
Location
United Kingdom
Sponsor
Medialis Ltd.
View Trial →
NCT07262762
Recruiting

Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

Enrollment
175 pts
Location
Iran
Sponsor
Cinnagen
View Trial →
NCT07141342
Recruiting

Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.

Enrollment
92 pts
Location
United States
Sponsor
Jonathan Pearlman
View Trial →
NCT07364175
Recruiting

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Enrollment
60 pts
Location
United Kingdom
Sponsor
Cambridge University Hospitals...
View Trial →
NCT07336797 Phase 2
Recruiting

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Enrollment
66 pts
Location
Egypt
Sponsor
Abdelrahman Mahmoud
View Trial →